IL17A and myeloid sarcoma: These findings suggest a complex interplay between metabolic networks and immune-inflammatory responses, including the negative relationships between α-DIPA with pro-inflammatory cytokines TNF-α and IL-17, further emphasizing the need to explore these interactions in the context of MS.